HOXB9 and ovarian carcinoma: To explore the correlation between HOXB9 and cisplatin resistance in ovarian cancer cells, we performed a Presto Blue assay to evaluate the effect of HOXB9 overexpression on cisplatin-induced apoptotic cell death.